J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like ADM Tronics Reports Fiscal Year 2017 June 29, 2017 AstraZeneca PLC Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D May 21, 2017 K2M First-To-Market With 3D-Printed Corpectomy Cage System Following FDA Clearance Of CAPRI Small 3D Static Featuring Lamellar 3D Titanium Technology June 27, 2017
K2M First-To-Market With 3D-Printed Corpectomy Cage System Following FDA Clearance Of CAPRI Small 3D Static Featuring Lamellar 3D Titanium Technology June 27, 2017
